These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38245712)

  • 1. Prediction of neoadjuvant chemotherapy pathological complete response for breast cancer based on radiomics nomogram of intratumoral and derived tissue.
    Zheng G; Hou J; Shu Z; Peng J; Han L; Yuan Z; He X; Gong X
    BMC Med Imaging; 2024 Jan; 24(1):22. PubMed ID: 38245712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting pathological complete response to neoadjuvant chemotherapy in breast cancer patients: use of MRI radiomics data from three regions with multiple machine learning algorithms.
    Zheng G; Peng J; Shu Z; Jin H; Han L; Yuan Z; Qin X; Hou J; He X; Gong X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):147. PubMed ID: 38512406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Two-Center study.
    Wang X; Hua H; Han J; Zhong X; Liu J; Chen J
    Clin Breast Cancer; 2023 Aug; 23(6):e331-e344. PubMed ID: 37321954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CT.
    Huang X; Mai J; Huang Y; He L; Chen X; Wu X; Li Y; Yang X; Dong M; Huang J; Zhang F; Liang C; Liu Z
    Clin Breast Cancer; 2021 Aug; 21(4):e388-e401. PubMed ID: 33451965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine Learning-Based Radiomics Nomogram Using Magnetic Resonance Images for Prediction of Neoadjuvant Chemotherapy Efficacy in Breast Cancer Patients.
    Chen S; Shu Z; Li Y; Chen B; Tang L; Mo W; Shao G; Shao F
    Front Oncol; 2020; 10():1410. PubMed ID: 32923392
    [No Abstract]   [Full Text] [Related]  

  • 6. CT-based delta-radiomics nomogram to predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma patients.
    Fan L; Yang Z; Chang M; Chen Z; Wen Q
    J Transl Med; 2024 Jun; 22(1):579. PubMed ID: 38890720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging-based radiomics nomogram for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer.
    Wu XH; Ruan ZT; Ke ZB; Lin F; Chen JY; Xue YT; Lin B; Chen SH; Chen DN; Zheng QS; Xue XY; Wei Y; Xu N
    Cancer Med; 2024 Jul; 13(14):e70001. PubMed ID: 39031016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinicopathological-imaging nomogram for the prediction of pathological complete response in breast cancer cases administered neoadjuvant therapy.
    Yang W; Yang Y; Zhang C; Yin Q; Zhang N
    Magn Reson Imaging; 2024 Sep; 111():120-130. PubMed ID: 38703971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.
    Mao N; Shi Y; Lian C; Wang Z; Zhang K; Xie H; Zhang H; Chen Q; Cheng G; Xu C; Dai Y
    Eur Radiol; 2022 May; 32(5):3207-3219. PubMed ID: 35066632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma.
    Lin P; Yang PF; Chen S; Shao YY; Xu L; Wu Y; Teng W; Zhou XZ; Li BH; Luo C; Xu LM; Huang M; Niu TY; Ye ZM
    Cancer Imaging; 2020 Jan; 20(1):7. PubMed ID: 31937372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics of contrast-enhanced spectral mammography for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer.
    Zhang K; Lin J; Lin F; Wang Z; Zhang H; Zhang S; Mao N; Qiao G
    J Xray Sci Technol; 2023; 31(4):669-683. PubMed ID: 37066960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
    Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
    [No Abstract]   [Full Text] [Related]  

  • 13. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.
    Qian B; Yang J; Zhou J; Hu L; Zhang S; Ren M; Qu X
    Front Endocrinol (Lausanne); 2022; 13():955250. PubMed ID: 36060977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of radiomics based on CE-MRI for predicting the efficacy of neoadjuvant chemotherapy in invasive breast cancer.
    Li Q; Huang Y; Xiao Q; Duan S; Wang S; Li J; Niu Q; Gu Y
    Br J Radiol; 2022 Oct; 95(1139):20220186. PubMed ID: 36005646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of response to neoadjuvant chemotherapy in advanced gastric cancer: A radiomics nomogram analysis based on CT images and clinicopathological features.
    Tan X; Yang X; Hu S; Ge Y; Wu Q; Wang J; Sun Z
    J Xray Sci Technol; 2023; 31(1):49-61. PubMed ID: 36314190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Based on Intratumoral and Peritumoral DCE-MRI Radiomics Nomogram.
    Liu Y; Li X; Zhu L; Zhao Z; Wang T; Zhang X; Cai B; Li L; Ma M; Ma X; Ming J
    Contrast Media Mol Imaging; 2022; 2022():6729473. PubMed ID: 36051932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer.
    Sang L; Liu Z; Huang C; Xu J; Wang H
    Clin Radiol; 2024 Jan; 79(1):60-66. PubMed ID: 37838543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma.
    Xu A; Chu X; Zhang S; Zheng J; Shi D; Lv S; Li F; Weng X
    BMC Cancer; 2022 Aug; 22(1):872. PubMed ID: 35945526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Intratumoral and Peritumoral Radiomics Nomogram Using Digital Breast Tomosynthesis for Preoperative Assessment of Lymphovascular Invasion in Invasive Breast Cancer.
    Xu M; Yang H; Sun J; Hao H; Li X; Liu G
    Acad Radiol; 2024 May; 31(5):1748-1761. PubMed ID: 38097466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.